Literature DB >> 8253976

Comparison of polymerase chain reaction, culture, and western immunoblot serology for diagnosis of Bordetella pertussis infection.

E Grimprel1, P Bégué, I Anjak, F Betsou, N Guiso.   

Abstract

Polymerase chain reaction (PCR) amplification of the pertussis toxin promoter region was used to detect Bordetella pertussis infection in nasopharyngeal aspirates collected from 24 infants and children infected with pertussis and 13 adult contacts during an epidemiological study. The sensitivity of this PCR assay was approximately one bacterium, and the assay was specific for B. pertussis in tests with other Bordetella species and other respiratory pathogens. The pertussis case definition required a cough with a duration of more than 21 days for infants and children and laboratory confirmation by serology as the primary detection method for infants, children, and adults. The sensitivity of PCR and culture on Bordet-Gengou agar medium was assessed with regard to the case definitions. In the group of infants and children (index cases), the sensitivities of the culture and the PCR were 54.1% (13 of 24) and 95.8% (23 of 24), respectively. In the adult group (household contacts), the sensitivities of the two methods were 15.4% (2 of 13) and 61.5% (8 of 13), respectively. PCR combined with pertussis-specific serology appears to be a useful tool for diagnosis of pertussis especially in epidemiological studies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8253976      PMCID: PMC266003          DOI: 10.1128/jcm.31.10.2745-2750.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Filamentous hemagglutinin of Bordetella pertussis: nucleotide sequence and crucial role in adherence.

Authors:  D A Relman; M Domenighini; E Tuomanen; R Rappuoli; S Falkow
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

2.  Pertussis toxin gene: nucleotide sequence and genetic organization.

Authors:  C Locht; J M Keith
Journal:  Science       Date:  1986-06-06       Impact factor: 47.728

3.  The return of pertussis.

Authors:  J W Bass; S R Stephenson
Journal:  Pediatr Infect Dis J       Date:  1987-02       Impact factor: 2.129

4.  Laboratory diagnosis of pertussis: the state of the art.

Authors:  I M Onorato; S G Wassilak
Journal:  Pediatr Infect Dis J       Date:  1987-02       Impact factor: 2.129

5.  Detection and identification of mycobacteria by amplification of mycobacterial DNA.

Authors:  A J Hance; B Grandchamp; V Lévy-Frébault; D Lecossier; J Rauzier; D Bocart; B Gicquel
Journal:  Mol Microbiol       Date:  1989-07       Impact factor: 3.501

6.  Detection of Mycoplasma pneumoniae by using the polymerase chain reaction.

Authors:  C Bernet; M Garret; B de Barbeyrac; C Bebear; J Bonnet
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

7.  The changing epidemiology of pertussis in young infants. The role of adults as reservoirs of infection.

Authors:  J D Nelson
Journal:  Am J Dis Child       Date:  1978-04

8.  Comparison of polymerase chain reaction with culture and enzyme immunoassay for diagnosis of pertussis.

Authors:  Q He; J Mertsola; H Soini; M Skurnik; O Ruuskanen; M K Viljanen
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

9.  Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction.

Authors:  J L Burg; C M Grover; P Pouletty; J C Boothroyd
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

10.  Evolutionary relationships in the genus Bordetella.

Authors:  B Aricò; R Gross; J Smida; R Rappuoli
Journal:  Mol Microbiol       Date:  1987-11       Impact factor: 3.501

View more
  24 in total

1.  Detection of Bordetella pertussis by rapid-cycle PCR and colorimetric microwell hybridization.

Authors:  G E Buck
Journal:  J Clin Microbiol       Date:  1996-06       Impact factor: 5.948

2.  Validation of nested Bordetella PCR in pertussis vaccine trial.

Authors:  E Reizenstein; L Lindberg; R Möllby; H O Hallander
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

3.  Detection of Bordetella pertussis in clinical specimens by PCR and a microtiter plate-based DNA hybridization assay.

Authors:  S Nelson; A Matlow; C McDowell; M Roscoe; M Karmali; L Penn; L Dyster
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

Review 4.  Laboratory diagnosis of pertussis: state of the art in 1997.

Authors:  F M Müller; J E Hoppe; C H Wirsing von König
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

5.  Rapid-cycle PCR method to detect Bordetella pertussis that fulfills all consensus recommendations for use of PCR in diagnosis of pertussis.

Authors:  D J Farrell; M McKeon; G Daggard; M J Loeffelholz; C J Thompson; T K Mukkur
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

6.  Polymorphism in the pertussis toxin promoter region affecting the DNA-based diagnosis of Bordetella infection.

Authors:  M Nygren; E Reizenstein; M Ronaghi; J Lundeberg
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

Review 7.  Relevance of nucleic acid amplification techniques for diagnosis of respiratory tract infections in the clinical laboratory.

Authors:  M Ieven; H Goossens
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

8.  Rapid diagnosis of pertussis using the Chinese hamster ovary cell cytotoxicity assay.

Authors:  S A Halperin; A Kasina; M Swift
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-03       Impact factor: 3.267

9.  Nested PCR optimized for detection of Bordetella pertussis in clinical nasopharyngeal samples.

Authors:  A Bäckman; B Johansson; P Olcén
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

10.  Immunomagnetic separation and solid-phase detection of Bordetella pertussis.

Authors:  M Stark; E Reizenstein; M Uhlén; J Lundeberg
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.